Key result
Non-invasive 252-lead mapping accurately identifies diverse atrial, ventricular, and pre-excitation arrhythmias.
Why the study?
Does non-invasive 3D 252-lead body surface electrocardiographic mapping accurately identify arrhythmia mechanisms and sources compared with invasive electrophysiological mapping in patients with cardiac rhythm and conduction disorders?
Does non-invasive 3D 252-lead body surface electrocardiographic mapping accurately identify arrhythmia mechanisms and sources compared with invasive electrophysiological mapping in patients with cardiac rhythm and conduction disorders?
Non-invasive 252-lead 3D body surface electrocardiographic mapping provides panoramic single-beat epicardial activation imaging that accurately localizes atrial and ventricular arrhythmia sources and guides catheter ablation and CRT lead placement.
Answers are grounded in this paper and cite their sources.
May support non-invasive arrhythmia localization; leaves open prospective validation before clinical adoption.
The authors describe a novel three-dimensional, 252-lead electrocardiography (ECG) and computed tomography (CT)-based non-invasive cardiac imaging and mapping modality. This technique images potentials, electrograms and activation sequences (isochrones) on the epicardial surface of the heart. This tool has been investigated in the normal cardiac electrophysiology and various tachyarrhythmic, conduction and anomalous depo-repolarisation disorders. The clinical application of this system includes a wide range of electrical disorders like atrial arrhythmias (premature atrial beat, atrial tachycardia, atrial fibrillation), ventricular arrhythmias (premature ventricular beat, ventricular tachycardia) and ventricular pre-excitation (Wolff-Parkinson-White syndrome). In addition, the system has been used in exploring abnormalities of the His-Purkinje conduction like the bundle branch block and intraventricular conduction disturbance and thereby useful in electrically treating the associated heart failure (cardiac resynchronisation). It has a potential role in furthering our understanding of abnormalities of ventricular action potential (depolarisation [Brugada syndrome and repolarisation], long QT and early repolarisation syndromes) and in evaluating the impact of drugs on His-Purkinje conduction and cardiac action potential.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2013) conducted a review in Cardiac arrhythmias (atrial tachycardia, atrial fibrillation, ventricular tachycardia, premature beats, Wolff-Parkinson-White syndrome) and His-Purkinje conduction disorders. 3D 252-lead body surface electrocardiographic imaging (ECGI) and mapping (ECM) combined with non-contrast thoracic CT vs. Standard 12-lead ECG and invasive electroanatomical mapping was evaluated on Diagnostic accuracy in identifying arrhythmia mechanisms and sites of origin compared with invasive electrophysiological mapping. Non-invasive 252-lead body surface electrocardiographic mapping accurately identifies arrhythmia mechanisms and chamber locations across atrial, ventricular, and pre-excitation disorders.
Synapse has enriched 10 related papers. Consider them for comparative context: